Carl Zeiss Financials
| CZMWF Stock | USD 59.30 4.43 8.07% |
Carl |
Understanding current and past Carl Zeiss Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Carl Zeiss' financial statements are interrelated, with each one affecting the others. For example, an increase in Carl Zeiss' assets may result in an increase in income on the income statement.
Carl Zeiss Stock Summary
Carl Zeiss competes with Carl Zeiss, Coloplast A/S, Straumann Holding, EssilorLuxottica, and HOYA. Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3531 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Goschwitzer Strasse 51-52, |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.zeiss.de/meditec-ag/home.html |
| Phone | 49 3641 220 115 |
| Currency | USD - US Dollar |
Carl Zeiss Key Financial Ratios
There are many critical financial ratios that Carl Zeiss' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Carl Zeiss Meditec reports annually and quarterly.| Return On Equity | 0.16 | |||
| Return On Asset | 0.0955 | |||
| Target Price | 138.8 | |||
| Beta | 0.8 | |||
| Z Score | 62.4 |
Carl Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Carl Zeiss's current stock value. Our valuation model uses many indicators to compare Carl Zeiss value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Carl Zeiss competition to find correlations between indicators driving Carl Zeiss's intrinsic value. More Info.Carl Zeiss Meditec is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers reporting about 0.60 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Carl Zeiss Meditec is roughly 1.67 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Carl Zeiss' earnings, one of the primary drivers of an investment's value.Carl Zeiss Meditec Systematic Risk
Carl Zeiss' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Carl Zeiss volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Carl Zeiss Meditec correlated with the market. If Beta is less than 0 Carl Zeiss generally moves in the opposite direction as compared to the market. If Carl Zeiss Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Carl Zeiss Meditec is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Carl Zeiss is generally in the same direction as the market. If Beta > 1 Carl Zeiss moves generally in the same direction as, but more than the movement of the benchmark.
Carl Zeiss January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Carl Zeiss help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Carl Zeiss Meditec. We use our internally-developed statistical techniques to arrive at the intrinsic value of Carl Zeiss Meditec based on widely used predictive technical indicators. In general, we focus on analyzing Carl Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Carl Zeiss's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 15.92 | |||
| Value At Risk | (5.41) | |||
| Potential Upside | 4.02 |
Complementary Tools for Carl Pink Sheet analysis
When running Carl Zeiss' price analysis, check to measure Carl Zeiss' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carl Zeiss is operating at the current time. Most of Carl Zeiss' value examination focuses on studying past and present price action to predict the probability of Carl Zeiss' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carl Zeiss' price. Additionally, you may evaluate how the addition of Carl Zeiss to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |